Friday May 13th, 2011: Presentation Reviews
0845 - 1200 FRI AM SESSION
0845-0910 Case Study: MASSIVE TRANSFUSION PROTOCOL FOR OB PATIENTS
Conna Hiltner, CLS(ASCP)
Shawnee Mission Medical Center, Merriam, KS
BIOGRAPHY:
I took my training at KU Medical Center, and have worked at Shawnee Mission Medical Center since
then, for the past 40 years. I have been in theTransfusion Service for 30 years. In addition to
Transfusion Service, I also serve as the hospital's Tissue Coordinator. I enjoy traveling with my family,
most recently traveling to Russia with my husband. I also keep busy with genealogy, cooking and
volunteering with my 2 daughters at a Girl Scout equestrian program.
OBJECTIVES: This presentation describes the:
1. OB cases that highlighted the need for a Massive Transfusion Protocol
2. Interdisciplinary team formed to develop it
3. Final protocol
4. On-going evaluation of effectiveness
0910-1000 Presentation: FOLLOW THAT PLATELET!
Peyton Metzel
Fenwal, Inc., Lake Zurich, IL
1000-1030 BREAK/VENDOR EXHIBITS
1030-1200 Presentation: NATIONAL HEALTHCARE SAFETY NETWORK (NHSN) BIOVIGILANCE COMPONENT
DEMONSTRATION
Alexis Harvey, Public Health Analyst
CDC Contractor - Emergint Technologies, Inc., Atlanta GA
BIOGRAPHY:
Alexis is trained in microbiology and epidemiology and has experience in tissueprocurement and
processing. She is now a Public Health Analyst in the Office of Blood, Organ, and Other Tissue Safety
at the Centers for Disease Control and Prevention helping to build Biovigilance in the United States.
OBJECTIVES:
1. To demonstrate major features of the Hemovigilance Module of the National
Healthcare Safety Network (NHSN).
2. To explain how CDC will protect the hemovigilance data received from facilities.
3. To explain how participating facilities can use their own data for process improvements.
4. To describe the steps necessary for facilities to join the NHSN.
1200-1315 Lunch and Vendor Exhibits
1315-1330 Business Meeting/Scholarship Paper
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
1330 - 1615 FRI PM SESSION
1330-1420 Presentation: BLOOD MANAGEMENT
Dr. Lowell Tilzer
K.U. Medical Center, Kansas City, KS
BIOGRAPHY:
Tilzer received his bachelor, MD, and PhD degrees, as well as his residency training at the University of
Kansas. He served on the School of Medicine faculty until 1992. Before returning to KU Medical Center,
he was CEO for the American Red Cross Southwest Blood Region. Dr. Tilzer returned to the Kansas
University Medical Center in 2004 as professor of Pathology for the KU School of Medicine. He serves
as Medical Director of the Clinical Laboratory and Chairman of the Department of Pathology and
Laboratory Medicine.
Tilzer is co-author of the Laboratory Test Handbook, third edition, the second largest selling book in
laboratory medicine. He has also published more than 50 articles in peer-reviewed journals. His
accomplishments include being the first to implement bar coding for laboratory specimen process,
discovery of progesterone receptors in meningiomas and being the first to suggest progestin therapy for
treatment of inoperable meningiomas. Tilzer also invented and patented novel techniques for
extracting DNA and RNA using gel barrier technology, which led to the founding of Isogene
Biotechnology.
OBJECTIVES:
1. Learn the adverse reactions due to:
a) Red Blood Cells
b) Platelets
c) Plasma
2. Using evidence based medicine, understand when to use the major blood components
3. Use of alternatives to blood components in a bleeding patient
1420-1445 Case Study: YOU ARE WHAT YOU EAT! AN INTERESTING TTP/HUS CASE STUDY
Misty Fowler
Saint Luke's Hospital, Kansas City, MO
1445-1500 BREAK
1500-1525 Case Study: A SICKLE IN A PICKLE
Julie Kirkegaard
Community Blood Center, Kansas City, MO
1525-1615 Presentation: CHARLES DREW AND YOU: THE VALUE OF DIRECTED DONATION
Ruby Russell, Clinical Laboratory Scientist
Saint Luke's Hospital, Kansas City
BIOGRAPHY:
American Red Cross - Executive Board Member of the Charles Drew Program, Kansas City, MO
Clinical Laboratory Scientist
INTRODUCTION:
Imagine yourself lying in a hospital bed needing a transfusion and you've just been told you have
formed your 4th alloantibody and your transfusion will have to wait. This is the reality for some
sickle cell patients across the country. So how does the blood service industry follow the new Healthy
People Initiatives for 2020 to "Prevent illness and disability related to blood disorders and the use of
blood products"1? The American Red Cross, Charles Drew Program, uses directed donations to improve
blood safety for patients with Sickle Cell Anemia.
OBJECTIVES:
1. Charles Drew Program Overview
2. Directed Donation importance/impact
3. Statistics for Charles Drew/Directed Donation
4. Personal accounts:
ο Ruby Russell (Kansas City Charles Drew Board Member)
ο Earnestine Diamond (KCMO Charles Drew Board Member & oldest living sickle cell patient)
ο Rachel Young (Kansas City Charles Drew Board Member)
5. How your organization/you can personally get involved
WEBSITE for Healthy People Initiatives: